On May 10, 2024, injectable PrEP (pre-exposure prophylaxis) was approved for use in Canada for the prevention of HIV. Apretude (cabotegravir) represents a significant advancement in HIV prevention, offering a promising alternative to daily oral PrEP medications.

Underlying all the hot, steamy scenes of the new limited series, Fellow Travellers, there are facts and realities with which the queer community can identify. These elements help to weave a beautiful story of love and loss.

Gonorrhea is the second most common bacterial STI in Canada. Within gbMSM communities, gonorrhea rates have been increasing. There is a higher prevalence of rectal and throat gonorrhea in gbMSM.